Status:
COMPLETED
Yoga Intervention for Cancer Survivors
Lead Sponsor:
Vanderbilt University Medical Center
Conditions:
Cancer Survivors
Yoga
Eligibility:
All Genders
18-90 years
Brief Summary
Impaired health related quality of life (HRQOL) including fatigue, problems with sleep and psychosocial well being (physical, emotional, and spiritual) have been noted in adult cancer survivors. Physi...
Detailed Description
The Yoga Program The yoga intervention will be developed by a certified yoga instructor. The yoga instructors teaching the classes will undergo training before teaching classes; all classes will embo...
Eligibility Criteria
Inclusion
- Survivor population
- Adults (18 years of age or above)
- Patients treated for any cancers between the ages of 18 and 65 years of age
- Received and concluded cancer treatment anytime from January 1, 2000 up to 1 month before start date of study
- Received cancer treatment and care at either Vanderbilt-Ingram Cancer Center (VICC) or Nashville General Hospital (NGH) or are currently receiving cancer survivorship care at the Vanderbilt REACH for Survivorship Clinic
- Obtain \*medical clearance to perform light exercise from primary care physician, oncologist or health care provider at REACH for Survivorship clinic (medical clearance needs to be obtained at least 2 weeks prior to starting yoga class).
- Have completed, if ever received, any chemotherapy treatment from January 1, 2000 up to 1 month before start date of study
- Patients with lymphedema due to cancer surgery/treatment are eligible
- Alive without evidence of recurrent disease
- Without evidence of a subsequent malignancy following initial cancer diagnosis
- Provide informed consent
- Should be able to sit on chair/floor and recline without assistance
- Can read and understand English
- Can have past experience with yoga or meditation
Exclusion
- Enrolled or attending a yoga class at time of recruitment
- Currently receiving active treatment for cancer
- Currently not in remission
- Have any additional health concerns such as brain metastases or ventricular-peritoneal shunts at time of participation
Key Trial Info
Start Date :
February 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01228955
Start Date
February 1 2010
End Date
March 1 2012
Last Update
April 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232